MyAverix Finance
HK · Healthcare
Luye Pharma Group Ltd (2186)
Drug Manufacturers - Specialty & Generic
Luye Pharma Group Ltd (2186) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $9.03B, P/E ratio is 16.14, net margin is 9.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2186
Luye Pharma Group Ltd (2186) — FAQ
What is Luye Pharma Group Ltd's market cap?
Luye Pharma Group Ltd (2186) has a reported market cap of $9.03B (data as of 2026-05-21).
What is 2186's P/E ratio?
The price-to-earnings (P/E) ratio for Luye Pharma Group Ltd (2186) is 16.14 (data as of 2026-05-21).
Does Luye Pharma Group Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Luye Pharma Group Ltd (2186). Check the MyAverix Finance app for the latest dividend data.
What sector is Luye Pharma Group Ltd in?
Luye Pharma Group Ltd (2186) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 2186 listed on?
2186 is listed on HK.
What is Luye Pharma Group Ltd's net margin?
Luye Pharma Group Ltd (2186) reports a net margin of 9.8% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.